Merit Medical Systems Receives FDA Warning Letter Regarding Merit Laureate Hydrophilic Guidewire
Merit Medical Systems, Inc. (Nasdaq: MMSI), today announced it received a warning letter from the U.S. Food and Drug Administration regarding modifications to the hydrophilic coating process for the Merit Laureate® Hydrophilic Guidewire after an inspection of the Company's facility in Galway, Ireland.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.